S-2E
Modify Date: 2024-01-06 17:14:04
S-2E structure
|
Common Name | S-2E | ||
|---|---|---|---|---|
| CAS Number | 155730-92-0 | Molecular Weight | 367.43800 | |
| Density | 1.189g/cm3 | Boiling Point | 599.089ºC at 760 mmHg | |
| Molecular Formula | C22H25NO4 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 316.118ºC | |
Use of S-2ES-2E is an orally active and noncompetitive HMG-CoA reductase and acetyl-CoA carboxylase inhibitor. S-2E has an anti-hyperlipidemic action. S-2E has the potential for familial hypercholesterolemia and mixed hyperlipidemia research[1][2]. |
| Name | 4-[[(3S)-1-(4-tert-butylphenyl)-5-oxopyrrolidin-3-yl]methoxy]benzoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | S-2E is an orally active and noncompetitive HMG-CoA reductase and acetyl-CoA carboxylase inhibitor. S-2E has an anti-hyperlipidemic action. S-2E has the potential for familial hypercholesterolemia and mixed hyperlipidemia research[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | In the liver, S-2E is converted into its active metabolite, S-2E-CoA. S-2E-CoA noncompetitively inhibits the enzymatic activities of both 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase and acetyl-CoA carboxylase at Ki=18.11 μM and Ki=69.2 μM, respectively[1]. S-2E (3-30 mg/kg) given orally suppresses the secretion rate of very-low-density lipoprotein (VLDL)-cholesterol and triglyceride in Triton WR-1339-injected rats. Furthermore, S-2E lowers the blood total cholesterol and triglyceride levels simultaneously in Zucker fatty rats[1]. |
| References |
| Density | 1.189g/cm3 |
|---|---|
| Boiling Point | 599.089ºC at 760 mmHg |
| Molecular Formula | C22H25NO4 |
| Molecular Weight | 367.43800 |
| Flash Point | 316.118ºC |
| Exact Mass | 367.17800 |
| PSA | 66.84000 |
| LogP | 4.17920 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.58 |
| Storage condition | 20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
~78%
S-2E CAS#:155730-92-0 |
| Literature: Ohno, Tomoyasu; Yano, Shin-Go; Yamada, Haruo; Shirasaka, Tetsuhiko; Yamamoto, Akira; Kobayashi, Kimiko; Ogawa, Kazuo Chemical and Pharmaceutical Bulletin, 1999 , vol. 47, # 11 p. 1549 - 1554 |
|
~%
S-2E CAS#:155730-92-0 |
| Literature: Ohno, Tomoyasu; Yano, Shin-Go; Yamada, Haruo; Shirasaka, Tetsuhiko; Yamamoto, Akira; Kobayashi, Kimiko; Ogawa, Kazuo Chemical and Pharmaceutical Bulletin, 1999 , vol. 47, # 11 p. 1549 - 1554 |
|
~%
S-2E CAS#:155730-92-0 |
| Literature: Ohno, Tomoyasu; Yano, Shin-Go; Yamada, Haruo; Shirasaka, Tetsuhiko; Yamamoto, Akira; Kobayashi, Kimiko; Ogawa, Kazuo Chemical and Pharmaceutical Bulletin, 1999 , vol. 47, # 11 p. 1549 - 1554 |
|
~%
S-2E CAS#:155730-92-0 |
| Literature: Ohno, Tomoyasu; Yano, Shin-Go; Yamada, Haruo; Shirasaka, Tetsuhiko; Yamamoto, Akira; Kobayashi, Kimiko; Ogawa, Kazuo Chemical and Pharmaceutical Bulletin, 1999 , vol. 47, # 11 p. 1549 - 1554 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| S-2E |
| (S)-(+)-4-[1-(4-tert-Butylphenyl)-2-oxo-pyrrolidin-4-yl]methoxybenzoic acid |